CD8+ MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis

European Journal of Immunology

Volumn 44, Issue 10, 2014, Pages 3119-3128

  Willing, Anne ^a   Leach, Oliver A ^b   Ufer, Friederike ^a   Attfield, Kathrine E ^b   Steinbach, Karin ^a   Kursawe, Nina ^a   Piedavent, Melanie ^a   Friese, Manuel A ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

CD161; IL 17; IL 18; MAIT cells; Multiple sclerosis

Indexed keywords

INTERLEUKIN 18; T LYMPHOCYTE RECEPTOR; VERY LATE ACTIVATION ANTIGEN 4; INTERLEUKIN 18 PROTEIN, HUMAN;

ARTICLE; BLOOD; BLOOD BRAIN BARRIER; BRAIN DAMAGE; CD8 POSITIVE MUCOSAL ASSOCIATED INVARIANT T CELL; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IN VITRO STUDY; LYMPHOCYTIC INFILTRATION; MEMORY T LYMPHOCYTE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UPREGULATION; FLOW CYTOMETRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION;

CD8-POSITIVE T-LYMPHOCYTES; CHEMOTAXIS, LEUKOCYTE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-18; LYMPHOCYTE ACTIVATION; MULTIPLE SCLEROSIS; T-LYMPHOCYTE SUBSETS;

EID: 84923179779     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344160     Document Type: Article

References (43)

1. Compston, A. and Coles, A., Multiple sclerosis. Lancet 2008; 372: 1502-1517.
2. Friese, M. A., Jakobsen, K. B., Friis, L., Etzensperger, R., Craner, M. J., McMahon, R. M., Jensen, L. T. et al., Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis. Nat. Med. 2008. 14: 1227-1235.
3. Willing, A. and Friese, M. A., CD8-mediated inflammatory central nervous system disorders. Curr. Opin. Neurol. 2012. 25: 316-321.
4. Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M. et al., Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 2000. 192: 393-404.
5. Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M. and Fugger, L., Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 2008. 172: 146-155.
6. Billerbeck, E., Kang, Y.-H., Walker, L., Lockstone, H., Grafmueller, S., Fleming, V., Flint, J. et al., Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc. Natl. Acad. Sci. USA 2010. 107: 3006-3011.
7. Dusseaux, M., Martin, E., Serriari, N., Péguillet, I., Premel, V., Louis, D., Milder, M. et al., Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 2011. 117: 1250-1259.
8. Gold, M. C., Cerri, S., Smyk-Pearson, S., Cansler, M. E., Vogt, T. M., Delepine, J., Winata, E. et al., Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol. 2010. 8: e1000407.
9. Le Bourhis L., Martin, E., Péguillet, I., Guihot, A., Froux, N., Coré, M., Lévy, E. et al., Antimicrobial activity of mucosal-associated invariant T cells. Nat. Immunol. 2010. 11: 701-708.
10. Kjer-Nielsen, L., Patel, O., Corbett, A. J., Le Nours, J., Meehan, B., Liu, L., Bhati M. et al., MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 2012. 491: 717-723.
11. Annibali, V., Ristori, G., Angelini, D. F., Serafini, B., Mechelli, R., Cannoni, S., Romano, S. et al., CD161(high)CD8+T cells bear pathogenetic potential in multiple sclerosis. Brain 2011. 134: 542-554.
12. Chua, W.-J., Truscott, S. M., Eickhoff, C. S., Blazevic, A., Hoft, D. F. and Hansen, T. H., Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection. Infect. Immun. 2012. 80: 3256-3267.
13. Havenith, S. H. C., Yong S, La., Henson, S. M., Piet, B., Idu, M. M., Koch, S. D., Jonkers, R. E. et al., Analysis of stem-cell-like properties of human CD161++IL-18Rα+ memory CD8+ T cells. Int. Immunol. 2012. 24: 625-636.
14. Turtle, C. J., Swanson, H. M., Fujii, N., Estey, E. H. and Riddell, S. R., A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy. Immunity 2009. 31: 834-844.
15. + semi-invariant T cells. Blood 2011. 118: 2752-2762.
16. Ussher, J.E., Bilton, M., Attwod, E., Shadwell, J., Richardson, R., de Lara, C., Mettke, E. et al., CD161(++) CD8(+) T cells including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner. Eur. J. Immunol. 2014. 44: 195-208.
17. Losy, J. and Niezgoda, A., IL-18 in patients with multiple sclerosis. Acta Neurol. Scand. 2001. 104: 171-173.
18. Nicoletti, F., Di Marco, R., Mangano, K., Patti, F., Reggio, E., Nicoletti, A., Bendtzen, K. et al., Increased serum levels of interleukin-18 in patients with multiple sclerosis. Neurology 2001. 57: 342-344.
19. Wang, H. H., Dai, Y. Q., Qiu, W., Lu, Z. Q., Peng, F. H., Wang, Y. G., Bao, J. et al., Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse. J. Clin. Neurosci. 2011. 18: 1313-1317.
20. Miyazaki, Y., Miyake, S., Chiba, A., Lantz, O. and Yamamura, T., Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. Int. Immunol. 2011. 23: 529-535.
21. Sallusto, F., Lenig, D., Förster, R., Lipp, M. and Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999. 401: 708-712.
22. Maggi, L., Santarlasci, V., Capone, M., Peired, A., Frosali, F., Crome, S. Q., Querci, V. et al., CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur. J. Immunol. 2010. 40: 2174-2181.
23. Ifergan, I., Kebir, H., Alvarez, J. I., Marceau, G., Bernard, M., Bourbonnière, L., Poirier, J. et al., Central nervous system recruitment of effector memory CD8+ T lymphocytes during neuroinflammation is dependent on α4 integrin. Brain 2011. 134: 3560-3577.
24. Micallef, M. J., Ohtsuki, T., Kohno, K., Tanabe, F., Ushio, S., Namba, M., Tanimoto, T. et al., Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur. J. Immunol. 1996. 26: 1647-1651.
25. Ahn, H. J., Maruo, S., Tomura, M., Mu, J., Hamaoka, T., Nakanishi, K., Clark, S. et al., A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma. J. Immunol. 1997. 159: 2125-2131.
26. Robinson, D., Shibuya, K., Mui, A., Zonin, F., Murphy, E., Sana, T., Hartley, S. B. et al., IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 1997. 7: 571-581.
27. Tominaga, K., Yoshimoto, T., Torigoe, K., Kurimoto, M., Matsui, K., Hada, T., Okamura, H. et al., IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells. Int. Immunol. 2000. 12: 151-160.
28. Glass, W. G., Lim, J. K., Cholera, R., Pletnev, A. G., Gao, J.-L. and Murphy, P. M., Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J. Exp. Med. 2005. 202: 1087-1098.
29. Reboldi, A., Coisne, C., Baumjohann, D., Benvenuto, F., Bottinelli, D., Lira, S., Uccelli, A. et al., C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 2009; 10: 514-523.
30. Illés, Z., Kondo, T., Newcombe, J., Oka, N., Tabira, T. and Yamamura, T., Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J. Immunol. 2000. 164: 4375-4381.
31. Illés, Z., Shimamura, M., Newcombe, J., Oka, N. and Yamamura, T. Accumulation of Valpha7.2-Jalpha33 invariant T cells in human autoimmune inflammatory lesions in the nervous system. Int. Immunol. 2004. 16: 223-230.
32. Kivisäkk, P., Mahad, D. J., Callahan, M. K., Trebst, C., Tucky, B., Wei, T., Wu, L. et al., Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc. Natl. Acad. Sci. USA 2003. 100: 8389-8394.
33. Balashov, K. E., Rottman, J. B., Weiner, H. L. and Hancock, W. W., CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. USA 1999. 96: 6873-6878.
34. Windhagen, A., Newcombe, J., Dangond, F., Strand, C., Woodroofe, M. N., Cuzner, M. L. and Hafler, D. A., Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 1995. 182: 1985-1996.
35. Schrijver, I. A., van Meurs, M., Melief, M. J., Wim Ang, C., Buljevac, D., Ravid, R., Hazenberg, M. P. et al., Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis. Brain 2001. 124: 1544-1554.
36. Buljevac, D., Flach, H. Z., Hop, W. C. J., Hijdra, D., Laman, J. D., Savelkoul, H. F. J., van Der Meché, F. G. A. et al., Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 2002. 125: 952-960.
37. Correale, J., Fiol, M. and Gilmore, W., The risk of relapses in multiple sclerosis during systemic infections. Neurology 2006. 67: 652-659.
38. Croxford, J. L., Miyake, S., Huang, Y.-Y., Shimamura, M. and Yamamura, T., Invariant V(alpha)19i T cells regulate autoimmune inflammation. Nat. Immunol. 2006. 7: 987-994.
39. Meierovics, A., Yankelevich, W.-J. C. and Cowley, S. C., MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proc. Natl. Acad. Sci. USA 2013. 110: E3119-E3128.
40. Chiba, A., Tajima, R., Tomi, C., Miyazaki, Y., Yamamura, T. and Miyake, S., Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis. Arthritis Rheum. 2012. 64: 153-161.
41. Abrahamsson, S. V., Angelini, D. F., Dubinsky, A. N., Morel, E., Oh, U., Jones, J. L., Carassiti, D. et al., Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis. Brain 2013. 136: 2888-2903.
42. Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K. et al., Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 2011. 69: 292-302.
43. Altman, J. D., Moss, P. A., Goulder, P. J., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I, McMichael, A. J. et al., Phenotypic analysis of antigen-specific T lymphocytes. Science 1996. 274: 94-96.